News Agency News Aggregator Journalist/Editor Broking House Others
WOCKPHARMA - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
CONGRATS TO ALL MY CLIENTS IN ADVANCE WHO BOUGHT MY CALL ASHOKA AND WOCKPHARMA
Wockhardt becomes first Indian company to get DCGI nod for two novel antibiotics. #MoneyTimes #BreakingNews #JustIn #NewsToday #NewsAlert #News
Wockhardt has received DCGI approval for 2 new antibiotics for acute bacterial skin and skin structure infections. This drug has great potential.
#Wockhardt को 2 नई एंटी-बॉयोटिक दवाओं को मिली मंजूरी, इन दवाओं का किन देशों में होगा एक्सपोर्ट और बजट से फार्मा सेक्टर को क्या हैं उम्मीदें? देखिए कंपनी के फाउंडर चेयरमैन हबील खोराकीवाला से खास बातचीत #ZBizExclusive #ZeeBudget2020 @SwatiKJain @WockhardtHosp
What wockhardt believes is the timeline of us fda clearance
Abishek, This is my multi-bagger idea. If the setup plays out then a 10+ X possible. I'm going to play this out very patiently. My average price is still higher than CMP buy I'll take it. #Wockhardt
#Wockhardt at very interesting juncture Disc: Invested
#CNBCTV18Market | Wockhardt surges sharply
#LMMarketSnippets - #Wockhardt becomes first Indian co to get DCGI nod for 2 new antibiotics - Govt drafting national fisheries policy with Rs 45000 crore budget - #GMRInfra to divest 49% in GMR Airports to #Tata Grp, #GIC and #SSG Capital Mgt Disclaimer:
#2019JAN16 #INTRADAY #BUY #WOCKPHARMA Precise Entry = 272.5 Exit = 281 15550 rupees profit as per 1:10 leverage. ROI=3.11% Precise level traded and profit is higher for the call. If you have followed our levels you can see it.
#Wockhardt share price gained 5 percent after the company received Indian regulatory approval for its two new antibiotics.